acetylcysteine has been researched along with olanzapine in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Altindag, A; Bulut, M; Dalkilic, A; Savas, HA; Virit, O | 1 |
| Amos, T; Chamberlain, SR; Fineberg, N; Ipser, JC; Rothbart, R; Siegfried, N; Stein, DJ | 1 |
| Rothbart, R; Stein, DJ | 1 |
| Baczynski, C; Sharma, V | 1 |
| Boz, Z; Hu, M; Huang, XF; Yu, Y | 1 |
4 review(s) available for acetylcysteine and olanzapine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Pharmacotherapy for trichotillomania.
Topics: Acetylcysteine; Adult; Benzodiazepines; Clomipramine; Humans; Naltrexone; Olanzapine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Trichotillomania | 2013 |
Pharmacotherapy of trichotillomania (hair pulling disorder): an updated systematic review.
Topics: Acetylcysteine; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Dronabinol; Humans; Narcotic Antagonists; Olanzapine; Selective Serotonin Reuptake Inhibitors; Trichotillomania | 2014 |
Pharmacotherapy for trichotillomania in adults.
Topics: Acetylcysteine; Adult; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clinical Trials as Topic; Clomipramine; Comorbidity; Female; Humans; Olanzapine; Treatment Outcome; Trichotillomania | 2020 |
4 other study(ies) available for acetylcysteine and olanzapine
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Beneficial effects of N-acetylcysteine in treatment resistant schizophrenia.
Topics: Acetylcysteine; Adult; Antipsychotic Agents; Benzodiazepines; Clopenthixol; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Resistance; Drug Therapy, Combination; Female; Free Radical Scavengers; Humans; Olanzapine; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology | 2009 |
N-acetylcysteine prevents olanzapine-induced oxidative stress in mHypoA-59 hypothalamic neurons.
Topics: Acetylcysteine; Animals; Antioxidants; Antipsychotic Agents; Autophagy; Cell Line; Cell Survival; Hypothalamus; Mice; Mitochondria; Mitophagy; Neurons; Olanzapine; Oxidative Stress; Reactive Oxygen Species | 2020 |